AbbVie Inc. — Director's Dealing 2020

Nov 19, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2020-11-09

Reporting Person: Sorg Elaine K. (Sr. V.P., U.S. Commercial Ops.)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.01 par value	17595	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option(Right to buy)	$114.36	2028-02-14	Common Stock (7080)		Direct
Option(Right to buy)	$79.02	2029-02-20	Common Stock (10384)		Direct
Option(Right to buy)	$93.50	2030-02-19	Common Stock (45009)		Direct

Footnotes

F1: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 2,360 shares on 2/15/2019, as to 2,360 shares on 2/15/2020 and becomes exercisable as to 2,360 shares on 2/15/2021.

F2: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 5,192 shares on 2/21/2020 and becomes exercisable as to 5,192 shares on 2/21/2021, and as to 5192 shares on 2/21/2022.

F3: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable as to 15,003 shares on 02/20/2021, as to 15,003 shares on 2/21/2022, and as to 15,003 shares on 2/21/2023.